R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Senior Oncology Account Manager

Field SalesConfirmed live in the last 24 hours
Full-timeRemote in USA$150k - $230k

About the Job

Requirements

  • A master's or bachelor's degree and 12–15+ years of biopharma industry experience are required.
  • At least 8–12+ years of prior oncology product sales experience is required.
  • A proven track record of product launch success in the oncology therapeutic space is required.
  • Oral oncolytic product launch experience is required.
  • Experience launching oncology products with companion diagnostics is required.
  • A proven record of performance in highly competitive marketplaces is required.
  • A proven record of performance in solo-representative selling environments is required.
  • Demonstrated success operating in small- or midsize biotechnology environments is required.
  • Ability to meet territorial travel requirements and travel to meetings, training, and programs as necessary is required.
  • Proven effectiveness in highly collaborative and cross-functional working environments is required.
  • A valid driver's license is required.
  • Permanent residence in the accountable territory is required.
  • Approximately 50% travel is required.

Responsibilities

  • Effectively market the company’s product portfolio in the designated territory.
  • Exceed assigned territory performance goals by positioning product benefits and use for appropriate patients.
  • Manage time effectively by focusing on engagements that drive brand value and prioritizing activities that positively affect patients.
  • Partner with internal stakeholders to remove barriers to care and support timely access to products for eligible patients.
  • Adapt between virtual and in-person engagements and develop business plans that reflect account communication preferences.
  • Analyze market data and turn insights into business plans, implementing them by engaging key targets through call optimization and resource utilization.
  • Develop sustained customer relationships across assigned accounts and proactively offer innovative, value-driven solutions.
  • Represent the company’s brands professionally, compliantly, ethically, and effectively.
  • Maintain a thorough understanding of disease states, company products, and relevant competitors, and communicate product value across digital and live channels.
  • Understand reimbursement processes and fulfillment pathways for oral oncolytics.
  • Manage the territory effectively and apply selling competencies.
  • Find effective ways to gain customer access in the modern landscape.
  • Drive team effectiveness and shared goals by leveraging and sharing expertise and information.
  • Manage territory resources and budget effectively.
  • Comply with laws, regulations, and company policies governing employee conduct.
  • Model corporate values and cultivate an energized team culture focused on patient impact.

Desired Qualifications

  • Experience in the non-small cell lung cancer (NSCLC) oncology space is preferred.
  • An advanced degree such as an MBA, PharmD, or PhD is preferred.
  • Strong organization, planning, project management, technical, and analytical skills are preferred.
  • Relevant experience such as sales operations, market research, or market access is preferred.
  • Ability to work independently to execute strategic and tactical plans under tight timelines is preferred.
  • Ability to deliver compelling presentations to individuals and groups and adapt messaging to engage the audience is preferred.
  • High proficiency in Microsoft PowerPoint, Excel, and Word is preferred.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs